期刊文献+

吲哚菁绿荧光法在乳腺癌前哨淋巴结活检中的应用 被引量:14

Clinical Application of Indocyanine Green Fluorescence in Sentinel Lymph Nodes Biopsy for Breast Cancer
原文传递
导出
摘要 目的评价吲哚菁绿荧光(ICG)法在乳腺癌患者前哨淋巴结活检(SLNB)中的应用价值。方法对2014年2月至2015年3月期间在我院住院且行SLNB的66例乳腺癌患者的临床资料进行回顾性分析,66例患者分别应用ICG法(ICG组,34例)和美蓝染色法(美蓝组,32例)来预测腋窝淋巴结转移情况,对此进行比较。结果所有66例患者中检出前哨淋巴结患者共59例,检出率为89.39%(59/66)。59例检出前哨淋巴结患者中共检出前哨淋巴结162枚,平均2.75枚/例。检出时间为(5.05±1.52)min。在ICG组前哨淋巴结检出率为97.06%(33/34),美蓝组前哨淋巴结检出率为81.25%(26/32),ICG组的前哨淋巴结检出率明显高于美蓝组(P<0.05)。59例检出前哨淋巴结中有32例是前哨淋巴结阳性,其中ICG组20例,美蓝组12例。所有患者均行ALND,有35例发现腋窝淋巴结转移,其中ICG组21例,美蓝组14例。ICG组和美蓝组的灵敏度和假阴性率比较差异无统计学意义(95.2%比85.7%,P>0.05;4.8%比14.3%,P>0.05)。结论 ICG法在乳腺癌患者SLNB的应用中的检出率明显高于美蓝组,且具有操作简单、灵敏度高的特点。 Objective To evaluate clinical value of indocyanine green(ICG) fluorescence in sentinel lymph node(SLN) biopsy(SLNB) for breast cancer. Method The SLNBs were performed in 66 patients with breast cancer, who were divided into ICG group(n=34) and methylene blue dye group(n=32) according to the tracing method. Results The SLNs were found in 59 patients, the detection rate was 89.39%(59/66). One hundred and sixty-two SLNs in 59 patients were detected, the average number of detected SLNs was 2.75. The SLNs detection rate was 97.06%(33/34) and 81.25%(26/32) in the ICG group and in the methylene blue dye group, respectively, which in the ICG group was significantly higher than that in the methylene blue dye group(P〈0.05). The positive SLNs were found in 32 cases, within which was 20 cases in the ICG group, 12 cases in the methylene blue dye group. The axillary lymph node metastases were found in 35 of 66 cases, within which was 21 cases in the ICG group, 14 cases in the methylene blue dye group. The sensitivity and false negative rate had no significant differences between the ICG group and the methylene blue dye group(sensitivity: 95.2% versus 85.7%, P〈0.05; false negative rate: 4.8% versus 14.3%, P〈0.05). Conclusion The ICG fluorescence in SLNB for breast cancer has many advantages, including shorter time, simple operation, high sensitivity, and high detection rate as compared with methylene blue dye.
出处 《中国普外基础与临床杂志》 CAS 2016年第2期221-224,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 乳腺癌 前哨淋巴结 吲哚菁绿 美蓝染色 Breast cancer Sentinel lymph node biopsy Indocyanine green Methylene blue dye
  • 相关文献

参考文献15

二级参考文献68

  • 1Fleissig A,Fallowfield LJ,Langridge CI,et al.Post-operative arm morbidity and quality of life.Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J].Breast Cancer Res Treat,2006; 95(3):279-293. 被引量:1
  • 2Veronesi U,Paganelli G,Viale G,et al.A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003; 349(6):546-553. 被引量:1
  • 3Julian TB,Krag D,Brown A,et al.Preliminary technical results of NSABP B-32,a randomized phase Ⅲ clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients[J].Breast Cancer Res Treat,2004; 88(Suppl 1):s11-s12. 被引量:1
  • 4Helyer LK,Coburn NG,Law CH,et al.Axillary staging is more accurate today than ever before:no increase in the false negative rate with wide-spread adoption of sentinel node technique[J].Breast Cancer Res Treat,2007; 106(Suppl 1):s127-s128. 被引量:1
  • 5Filippakis GM,Zografos G.Contraindications of sentinel lymph node biopsy:are there any really?[J].World J Surg Oncol,2007; 5(1):10-20. 被引量:1
  • 6Lyman GH,Giuliano AE,Somerfield MR,et al.American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].J Clin Oncol,2005; 23(30):7703-7720. 被引量:1
  • 7Silverstein MJ,Lagios MD,Recht A,et al.Image-detected breast cancer:state of the art diagnosis and treatment[J].J Am Coll Surg,2005; 201(4):586-597. 被引量:1
  • 8Carlson RW,Anderson BO,Burstein HJ,et al.NCCN breast cancer clinical practice guidelines in oncology.Version 1,2009.Available at:http://www.nccn.org/physician_gls/ PDF/breast.pdf.Accessed January 25,2009. 被引量:1
  • 9Goldhirsch A,Wood WC,Gelber RD,et al.Progress and promise:highlights of the international expert consensus on the primary therapy of early breast cancer 2007[J].Ann Oncol,2007; 18(7):1133-1144. 被引量:1
  • 10王永胜 B2.乳腺癌局部区域治疗,进展与共识.中国医学论坛报,2009,35(12). 被引量:7

共引文献587

同被引文献82

引证文献14

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部